基于表型特异激活反感性寡核酸的特异性DNA纳米结构
Lok Ting Chu1, Hoi Kwan Kwong2, Chenyu Cui2
1Department of Biomedical Engineering, City University of Hong Kong, 83 Tat Chee Avenue, Hong Kong Special Administrative Region, China; Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Guang Dong Medical University, 524023, Zhanjiang, China.
Talanta
|November 18, 2023
概括
研究人员开发了一种Y形DNA纳米结构,以提高基因治疗的特异性. 这种新的方法增强了反感性寡核酸 (ASO) 输送,准癌细胞,同时为精准医学节省健康细胞.
科学领域:
- 生物技术是生物技术.
- 分子生物学分子生物学
- 纳米医学是一种纳米医学.
背景情况:
- 反感性寡核酸 (ASOs) 是关键的基因治疗药物,但具有有限的特异性.
- 低特异性可能会阻碍基于ASO的治疗的有效性和安全性.
- 开发增强ASO特异性的策略对于推进基因治疗至关重要.
研究的目的:
- 设计一个Y形DNA纳米结构,以提高ASO基因疗法的特异性.
- 整合一个检测触发器,用于表型特定激活和顺序ASO释放.
- 评估纳米结构在向癌细胞中的有效性和安全性.
主要方法:
- 设计和构建一个Y形DNA纳米结构,其中包含一个检测触发器.
- 整合表型特定的微RNA-21 (miR21) 激活.
- 对于Bcl2反感性寡核酸 (ASO) 的序列释放机制.
- 在体外评估Bcl2mRNA下调和诱导乳腺癌细胞中的细胞死亡.
- 评估纳米结构对非癌细胞的影响.
主要成果:
- 这种Y形DNA纳米结构成功降低了Bcl2mRNA表达的50%以上.
- 在接受治疗的乳腺癌细胞中观察到超过60%的细胞死亡诱导.
- 该方法没有证明对非癌细胞造成重大损害,突出显示了其选择性.
- 该纳米结构有效地将生物标记器传感与向基因沉默相结合.
结论:
- 开发的Y形DNA纳米结构为提高基因治疗中ASO特异性提供了一个有希望的策略.
- 这种超神学方法通过整合生物标志物检测和向治疗,为精准医学带来了潜力.
- 可定制的设计允许特定的目标序列,为定制的基因疗法铺平了道路.
相关概念视频
siRNA - Small Interfering RNAs
16.8K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.8K
Experimental RNAi
6.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K
DNA-only Transposons
14.5K
DNA-only transposons are called autonomous transposons since they code for the enzyme transposase that is required for the transposition mechanism. Insertion of transposons can alter gene functions in multiple ways. They can mutate the gene, alter gene expression by introducing a novel promoter or insulator sequence, introduce new splice sites, and change the mRNA transcripts produced, or remodel chromatin structure.
The donor site from where the transposon is excised is either degraded or...
The donor site from where the transposon is excised is either degraded or...
14.5K
RNA Interference
26.1K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.1K


